---
title: "002950.SZ (002950.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002950.SZ/news.md"
symbol: "002950.SZ"
name: "002950.SZ"
parent: "https://longbridge.com/en/quote/002950.SZ.md"
datetime: "2026-05-20T02:12:49.993Z"
locales:
  - [en](https://longbridge.com/en/quote/002950.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002950.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002950.SZ/news.md)
---

# 002950.SZ (002950.SZ) — Related News

### [Domestic and international dual-drive, Allmed Medical's revenue and net profit both grew in the first quarter](https://longbridge.com/en/news/284237316.md)
*2026-04-27T14:40:38.000Z*
> On April 27th, Allmed Medical (002950) disclosed that in 2025, the company achieved operating revenue of 3.672 billion y

### [Allmed Medical: Net profit in 2025 is expected to decline by 32.49% year-on-year, proposing a dividend of 1.46 yuan per 10 shares](https://longbridge.com/en/news/284203016.md)
*2026-04-27T11:14:29.000Z*
> On April 27th, Allmed Medical released its annual report, expecting operating revenue of 3.672 billion yuan in 2025, a y

### [Discovering Undiscovered Gems in Global for April 2026](https://longbridge.com/en/news/282522762.md)
*2026-04-13T10:02:46.000Z*
> As global markets show resilience with notable gains, investor sentiment has shifted positively, creating opportunities 

### [](https://longbridge.com/en/news/281819626.md)
*2026-04-07T02:16:54.000Z*
> The A-share medical consumables concept experienced fluctuations and surged during the trading session, with INTCO risin

### [](https://longbridge.com/en/news/278989016.md)
*2026-03-13T05:43:16.000Z*
> A-share medical consumables stocks continue to rise, ZHYL and INTCO are approaching a 20% limit-up, Allmed Medical and B

### [National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance](https://longbridge.com/en/news/274372521.md)
*2026-01-31T02:39:00.000Z*
> On January 31, according to the National Healthcare Security Administration, the new national medical insurance drug lis

### [GRANDPHARMA: TLX591-CDx new drug listing application accepted by the China National Medical Products Administration](https://longbridge.com/en/news/272964059.md)
*2026-01-19T09:35:00.000Z*
> According to a report from Economic Information Agency on the 19th, GRANDPHARMA announced that the group has officially 

### [Allmed Medical: Completed the repurchase of 0.8379% of the company's shares, with a total payment of 50.6186 million yuan](https://longbridge.com/en/news/272812158.md)
*2026-01-16T09:21:29.000Z*
> Allmed Medical announced that the company has cumulatively repurchased 5.3062 million shares through the centralized bid

### [Allmed Medical: Net profit in the third quarter was 149 million yuan, a year-on-year increase of 90.57%](https://longbridge.com/en/news/263268008.md)
*2025-10-29T10:56:16.000Z*
> On October 29th, Allmed Medical released its Q3 2025 report, showing a third-quarter operating revenue of 920 million yu